Skip to content

A Randomised Controlled Trial of Lumbar Drainage to Treat Communicating Hydrocephalus After Severe Intraventricular Hemorrhage

Lumbar Drainage for Communicating Hydrocephalus After Intraventricular Hemorrhage: a Randomised, Controlled Trial(LUCAS-IVH: LUmbar CAtheter for Severe IntraVentricular Hemorrhage)

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01041950
Acronym
LUCAS-IVH
Enrollment
30
Registered
2010-01-05
Start date
2012-05-31
Completion date
2015-07-31
Last updated
2016-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracerebral Hemorrhage, Obstructive Hydrocephalus

Keywords

intracerebral hemorrhage, intraventricular hemorrhage, hydrocephalus, Intracerebral hemorrhage with severe ventricular involvement and obstructive hydrocephalus

Brief summary

The purpose of this study is to determine if usage of early lumbar drainage leads to less shunt surgery and less catheter associated complications in patients with communicating hydrocephalus after intracerebral hemorrhage with severe ventricular involvement.

Detailed description

All patients requiring external ventricular drain (EVD) for treatment of acute obstructive hydrocephalus receive intraventricular fibrinolysis with rt-PA via the ventricular catheter. Lumbar drainage (LD) is inserted at a timepoint, when communication between the internal and the external CSF-spaces is recognizable on CT (opening of third and fourth ventricle and aqueduct).

Interventions

Lumbar CSF drainage is started after communication between the internal and external CSF-spaces is seen on CT.

Sponsors

University of Freiburg
CollaboratorOTHER
University of Erlangen-Nürnberg Medical School
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* supratentorial intracerebral hemorrhage \<60ml * intraventricular hemorrhage with casting of the third and fourth ventricles * obstructive hydrocephalus with need of external ventricular drainage * GCS \<9 on admission or within 48h of symptom onset * admission within 48h of symptom onset * preceding modified Rankin scale ≤3 * age 18-85 years

Exclusion criteria

* ICH related to oral anticoagulation, trauma, tumor, arteriovenous malformation, aneurysm, systemic thrombolysis or sinus thrombosis * infratentorial hemorrhage * pregnancy * admission 48h after symptom onset * preceding modified Rankin scale \>3

Design outcomes

Primary

MeasureTime frameDescription
Requirement of permanent VP-shunt14 daysif three attempts to clamp the EVD (control group) or LD (treatment group) fail, or overall extra-corporal drainage time exceeds 14 days, a VP-shunt is placed.

Secondary

MeasureTime frameDescription
Safety aspectsduring hospital stay(i) catheter-associated infections (ii) fibrinolysis- and catheter-associated bleedings (iii)overdrainage and herniation
mortality and outcome3 and 6 monthsmodified Rankin Scale 3 and 6 months after treatment, as well as in-hospital mortality.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026